ESSA Pharma Inc (EPIX)
6.88
-0.07
(-1.01%)
USD |
NASDAQ |
May 03, 16:00
6.97
+0.09
(+1.31%)
Pre-Market: 20:00
ESSA Pharma Cash from Investing (TTM): 6.200M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 6.200M |
September 30, 2023 | -3.527M |
June 30, 2023 | -6.610M |
March 31, 2023 | -16.22M |
December 31, 2022 | -43.55M |
September 30, 2022 | -53.05M |
June 30, 2022 | -49.71M |
March 31, 2022 | -37.64M |
December 31, 2021 | -46.01M |
September 30, 2021 | -35.01M |
June 30, 2021 | -56.75M |
March 31, 2021 | -56.74M |
December 31, 2020 | -21.74M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 |
Date | Value |
---|---|
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | -0.01M |
June 30, 2016 | -0.0697M |
March 31, 2016 | -0.1188M |
December 31, 2015 | -0.1205M |
September 30, 2015 | -0.1741M |
June 30, 2015 | -0.1143M |
March 31, 2015 | -0.0652M |
December 31, 2014 | -0.0555M |
September 30, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-56.75M
Minimum
Jun 2021
6.200M
Maximum
Dec 2023
-32.34M
Average
-37.64M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |